Target intelligence / Profile preview

Perennial ryegrass pollen allergen (Lol p)

Target
Lol p
Molecular classification
Allergen, Beta-expansin, Profilin, Polcalcin, Plant protein
01

Overview

Perennial ryegrass pollen allergens (Lol p) are a group of potent proteins derived from the pollen of Lolium perenne, which serve as major environmental triggers for respiratory allergies in temperate climates worldwide. These allergens, primarily the major components Lol p 1 (a beta-expansin) and Lol p 5, are recognized by the immune system of sensitized individuals, leading to the production of allergen-specific IgE antibodies. Upon inhalation, the allergens cross-link IgE bound to the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine that cause symptoms of allergic rhinitis and asthma. In the pharmaceutical context, these allergens are the active ingredients in allergen-specific immunotherapy (AIT) products, which are designed to desensitize the patient's immune system. By administering controlled, escalating doses of the allergen, AIT induces long-term immunological tolerance by promoting a shift from a pro-allergic Th2 response to a protective Th1 and regulatory T-cell response.

Other names
Lolium perenne allergensRyegrass pollen allergensLolium perenne pollen allergensLol p 1Lol p 5
02

Mechanism of action

Induction of immune tolerance through allergen-specific immunotherapy (AIT), which involves Th2-to-Th1 immune deviation, activation of regulatory T cells (Tregs), and the production of allergen-specific blocking antibodies such as IgG4 to inhibit IgE-mediated mast cell degranulation.

03

Biological functions

Cell wall looseningPollen-stigma interactionActin bindingImmune responseIgE binding
04

Disease associations

Allergic rhinitisAllergic conjunctivitisAllergic asthmaAnaphylaxisThunderstorm asthma
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsOral mucosa swellingAsthma exacerbation
06

Interacting drugs

Oralair

4 more in the full profile.

07

Biomarkers

Allergen-specific IgE (sIgE)Allergen-specific IgG4 (sIgG4)Skin prick test (SPT) wheal diameterBasophil activation test (BAT)

Beyond the preview

Go deeper on Perennial ryegrass pollen allergen (Lol p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perennial ryegrass pollen allergen (Lol p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call